HEPATITIS C VIRUS NUCLEIC ACID (HCV) - ANVISA Registration 82149920123

Access comprehensive regulatory information for HEPATITIS C VIRUS NUCLEIC ACID (HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 82149920123 and manufactured by DNA-TECHNOLOGY, RESEARCH & PRODUCTION. The registration is held by GENESTAR INOVAÇÕES E EQUIPAMENTOS MÉDICOS LTDA with validity until Jun 23, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ABBOTT MOLECULAR INC, ROCHE MOLECULAR SYSTEMS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.